SU‐E‐T‐390: Real‐Time Measurement of Urethral Dose and Position Using a RADPOS Array during Permanent Seed Implantation for Prostate Brachytherapy
Bibliographic record
Abstract
Purpose: The new in vivo dosimetry tool, RADPOS, combines MOSFET dosimetry with an electromagnetic positioning sensor. It has recently been modified to include a MOSFET array rather than a single MOSFET for dose monitoring at five points along the detector axis. The detector is in use as part of a clinical trial which is the first to measure both urethral dose and internal motion concurrently during permanent seed implantation for prostate brachytherapy using a single probe. Methods: The RADPOS detector was secured inside a Foley catheter inside the patientˈs urethra. Spatial coordinates of the RADPOS detector were read every 0.5 s and the timing of events such as needle insertion was noted. MOSFET readings were taken over two ten minute periods once all seeds had been implanted both before and after the TRUS probe was removed. Results: Locations of the dosimeters could be inferred using a marker located at the end of the detector wire which is visible on fluoroscopy images. Although detector position varied slightly between patients, on average one dose point was inside the bladder, two/three dose points were within the prostatic urethra, and one/two dose points were at or inferior to the apex of the prostate. Maximum integral dose in the prostatic urethral ranged from 110–195 Gy, and it was found that the dose can change up to 63 cGy depending on whether the rectal probe is in place. The average change in displacement from the beginning of the procedure to the end for all patients was Δr=(5.5 ± 2.2) mm, with changes in individual coordinates of Δx (right/left) = (0.1–2.6) mm, Δy (superior/inferior) = (0.3–8.7) mm, and Δz (anterior/posterior) = (1.2–5.0) mm. Conclusions: The modified RADPOS is a powerful tool that can provide accurate real time dose and position information for use during prostate brachytherapy. This project has been supported by grants from The Health Technology Exchange, Ontario Research Funds RE‐04‐026, The Ottawa Hospital Cancer Centre Foundation and by financial and technical support from Best Medical Canada and Ascension Technology Corporation.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.001 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".